Neonatal jaundice. Neonatal jaundice due to unspecified causes
Conditions
Interventions
Intervention 1: Intervention: Oral agar 500mg in 10ml distilled water were administered orally four times a day using 10ml syringes while using phototherapy. Intervention 2: Control: 10ml distilled w
Treatment - Drugs
Placebo
Intervention: Oral agar 500mg in 10ml distilled water were administered orally four times a day using 10ml syringes while using phototherapy
Control: 10ml distilled water were administered orally four times a day using 10ml syringes while using phototherapy
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Term neonates admitted with non-hemolytic jaundice.All cases were otherwise healthy, breast fed, full term neonates with birth weight more than 2500g, and TSB of 13-25 mg/dl. Exclusion criteria: Infants with any hemolytic disease (Rh or ABO incompatibility), sepsis or signs of dehydration such as decreasing neonatal reflexes and lethargy or unwillingness to feeding, those who were older than 10 days and infants who required exchange transfusion.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased serum bilirubin level. Timepoint: 6, 12, 24 hours after starting phototherapy. Method of measurement: Auto analyzer, Selectra E. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased duration of phototherapy. Timepoint: During hospitalization. Method of measurement: Calculating the hours of phototherapy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Jahangiri
Kashan University of Medical science
Outcome results
None listed